SFS
HEPA

Sowell Financial Services’s Hepion Pharmaceuticals HEPA Stock Holding History

Sowell Financial Services’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11
Closed -$18K – 1459
2021
Q1 		$18K Buy
11
+4
+57% +$8.77K ﹤0.01% 2092
2020
Q4 		$16K Buy
+7
New +$18.1K ﹤0.01% 1832
2020
Q3 		– Hold
0
– – – 2605
2020
Q2 		– Hold
0
– – – 2548
2020
Q1 		– Hold
0
– – – 2534
2019
Q4 		– Hold
0
– – – 2349
2019
Q3 		– Hold
0
– – – 2410

Other funds holding HEPA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Sowell Financial Services's HEPA Position: Q2 2021 in Review

Sowell Financial Services sold out of Hepion Pharmaceuticals (HEPA) in Q2 2021, closing a stake of 11 shares — an estimated $18K sold.

Sowell Financial Services first reported a position in HEPA in Q4 2020 and held it in 2 quarters. The position peaked at $18K in Q1 2021. 43 funds tracked by Wall St. Rank hold HEPA as of Q2 2021.

  • Sowell Financial Services reported no remaining Hepion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 11 Hepion Pharmaceuticals shares in Q2 2021, an estimated $18K.
  • Sowell Financial Services first reported a position in Hepion Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Sowell Financial Services's Hepion Pharmaceuticals position peaked at $18K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.